DRMAW
Dermata Therapeutics, Inc.
Set alert
0.00 USD 0.00 -50.00%
0.0005 Day range 0.0011
0.0005 52-week range 0.0011
- YTD
- -96.81%
- 1 year
- -96.81%
- Open
- 0.0229
- Prev close
- 0.0012
- Mkt cap
- 409
- Vol
- 146.06K
- Avg vol
- 0
- EPS
- -2.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0005
- High
- 0.0011
- Forward P/E
- 0.00
- Beta
- 0.79
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-4841.09 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.3×
FY 2019 5y median -0.3× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.3×
FY 2019 5y median 0.8× FY 2025
P/FCF -0.3×
FY 2019 5y median -0.3× FY 2025
EV/EBITDA 0.7×
FY 2019 5y median 0.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -361.0%
FY 2019 5y median -361.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -121.5%
FY 2019 5y median -122.7% FY 2025
ROIC -124.9%
FY 2019 5y median -126.5% FY 2025
ROA -96.1%
FY 2019 5y median -97.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 37.9%
FY 2019 FY 2025
EPS (diluted) 89.8%
FY 2019 FY 2025
Free Cash Flow 30.5%
FY 2019 FY 2025
Financial Health
Current Ratio 4.8×
FY 2019 5y median 4.9× FY 2025
Quick Ratio 4.8×
FY 2019 5y median 4.9× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2019 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31